\-\ Texto\\:\\ \ \(0\)\
\-\ laboratory\\ data\\:\\ \\ \ \(0\)\
\-\ cbc\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ 12\\.6\ \(1\)\
\-\ 4\\.4\\ \\>\\-\\-\\-\\-\\<192\ \(1\)\
\-\ \\ \\ \\ \\ \\ \\ 36\\.5\ \(1\)\
\-\ \\ \ \(1082074\)\
\-\ tsh\\ \\&\\#8211\\;\\ 0\\.05\\ uiu\\/ml\\.\\ \\(0\\.27\\-4\\.20\\)\ \(0\)\
\-\ free\\ t4\\ \\&\\#8211\\;\\ 2\\.49\\ ng\\/dl\\ \\(1\\.01\\-1\\.79\\)\ \(0\)\
\-\ unavailable\ \(26\)\
\-\ 24\\ hr\\ radioactive\\ iodine\\ uptake\\ \\(raiu\\)\\ was\\ 0\\.4\\%\\ \\(normal\\ 8\\-30\\%\\)\\.\\ \\ scintigraphy\\ utilizing\\ tc99m\\ pertechnetate\\ demonstrated\\ almost\\ no\\ trapping\\ of\\ the\\ radiopharmaceutical\\ in\\ the\\ thyroid\\ bed\\.\\ \\ there\\ was\\ homogeneously\\ decreased\\ activity\\.\ \(0\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ differential\\ diagnosis\\:\\ \\(hyperthyroidism\\ and\\ depressed\\ raiu\\)\ \(0\)\
\-\ 1\\.\\	subacute\\ thyroiditis\\ \\(also\\ known\\ as\\ de\\ quervain\\'s\\ thyroiditis\\ or\\ granulomatous\\ thyroiditis\\)\\ \ \(0\)\
\-\ 2\\.\\ \\ \\ \\ \\ \\ silent\\ lymphocytic\\ thyroiditis\\ \\(often\\ occurs\\ in\\ the\\ postpartum\\ period\\ and\\ is\\ then\\ referred\\ to\\ as\\ \\"postpartum\\ thyroiditis\\"\ \(0\)\
\-\ 3\\.\\	exogenous\\ thyroid\\ hormone\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ a\\.\\	iatrogenic\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ b\\.\\	factitious\\ \ \(0\)\
\-\ 4\\.\\	struma\\ ovarii\ \(0\)\
\-\ a\\ 48\\-year\\-old\\ woman\\ with\\ newly\\ diagnosed\\ hyperthyroidism\\.\\ \\ she\\ was\\ clinically\\ suspected\\ of\\ having\\ grave\\&\\#8217\\;s\\ disease\\.\ \(0\)\
\-\ subacute\\ thyroiditis\\ is\\ a\\ benign\\,\\ self\\-limited\\ inflammatory\\ disease\\ of\\ the\\ thyroid\\ gland\\.\\ \\ \ \(0\)\
\-\ \\ one\\ particular\\ variety\\ of\\ thyrotoxic\\ subacute\\ thyroiditis\\ is\\ silent\\ lymphocytic\\ thyroiditis\\.\\ \\ it\\ is\\ similar\\ in\\ manifestation\\ to\\ subacute\\ granulomatous\\ thyroiditis\\ or\\ de\\ quervain\\'s\\ thyroiditis\\,\\ except\\ for\\ the\\ absence\\ of\\ pain\\,\\ tenderness\\ and\\ prodromal\\ systemic\\ symptoms\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroiditis\\:\\ 0\\.2846002087225715\ \(0\)\
\-\ subacute\\:\\ 0\\.10540148137315347\ \(0\)\
\-\ quervain\\:\\ 0\\.07420102053171528\ \(0\)\
\-\ 8211\\:\\ 0\\.06753614379556196\ \(0\)\
\-\ silent\\:\\ 0\\.061707914915078155\ \(0\)\
\-\ postpartum\\:\\ 0\\.059389048984146535\ \(0\)\
\-\ raiu\\:\\ 0\\.05645268696923133\ \(0\)\
\-\ de\\:\\ 0\\.05461561738497451\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.05307386113425163\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.052386755711346385\ \(0\)\
\-\ thyroid\\:\\ 0\\.05051412180179871\ \(0\)\
\-\ \\#\\:\\ 0\\.04834163392703204\ \(0\)\
\-\ \\&\\:\\ 0\\.043289248444347575\ \(0\)\
\-\ 192\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ 2\\.49\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ thyrotoxic\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ prodromal\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ granulomatous\\:\\ 0\\.039655485978243796\ \(0\)\
\-\ 0\\.27\\-4\\.20\\:\\ 0\\.03904986174714689\ \(0\)\
\-\ 1\\.01\\-1\\.79\\:\\ 0\\.03904986174714689\ \(0\)\
\-\ 48\\-year\\-old\\:\\ 0\\.03904986174714689\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.03774201245908408\ \(0\)\
\-\ 36\\.5\\:\\ 0\\.03571742337907023\ \(0\)\
\-\ 0\\.05\\:\\ 0\\.03571742337907023\ \(0\)\
\-\ factitious\\:\\ 0\\.03571742337907023\ \(0\)\
\-\ ovarii\\:\\ 0\\.03376807189778098\ \(0\)\
\-\ struma\\:\\ 0\\.03302696286014993\ \(0\)\
\-\ 12\\.6\\:\\ 0\\.03238498501099357\ \(0\)\
\-\ exogenous\\:\\ 0\\.03238498501099357\ \(0\)\
\-\ 4\\.4\\:\\ 0\\.031818720416491725\ \(0\)\
\-\ self\\-limited\\:\\ 0\\.031818720416491725\ \(0\)\
\-\ 8\\-30\\:\\ 0\\.0313121794758291\ \(0\)\
\-\ 8217\\:\\ 0\\.0313121794758291\ \(0\)\
\-\ grave\\:\\ 0\\.030435633529704315\ \(0\)\
\-\ pertechnetate\\:\\ 0\\.029694524492073267\ \(0\)\
\-\ uiu\\/ml\\:\\ 0\\.029362827994539847\ \(0\)\
\-\ tc99m\\:\\ 0\\.029362827994539847\ \(0\)\
\-\ \\;\\:\\ 0\\.029212805602681642\ \(0\)\
\-\ radioactive\\:\\ 0\\.02876108211495328\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.02876108211495328\ \(0\)\
\-\ utilizing\\:\\ 0\\.028226343484615665\ \(0\)\
\-\ ng\\/dl\\:\\ 0\\.027745173010784014\ \(0\)\
\-\ 0\\.4\\:\\ 0\\.027521519089462418\ \(0\)\
\-\ newly\\:\\ 0\\.027307808692487254\ \(0\)\
\-\ trapping\\:\\ 0\\.02671837445165873\ \(0\)\
\-\ manifestation\\:\\ 0\\.026536930567125815\ \(0\)\
\-\ iodine\\:\\ 0\\.0258727462475065\ \(0\)\
\-\ depressed\\:\\ 0\\.0258727462475065\ \(0\)\
\-\ unavailable\\:\\ 0\\.02572010827484025\ \(0\)\
\-\ iatrogenic\\:\\ 0\\.02502211784289555\ \(0\)\
\-\ b\\.\\:\\ 0\\.024412734642707355\ \(0\)\
\-\ \\(\\:\\ 0\\.024310250402437613\ \(0\)\
\-\ variety\\:\\ 0\\.02429960725131219\ \(0\)\
\-\ t4\\:\\ 0\\.024081038145173938\ \(0\)\
\-\ homogeneously\\:\\ 0\\.023975370324410595\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.023871975107002116\ \(0\)\
\-\ bed\\:\\ 0\\.023871975107002116\ \(0\)\
\-\ hormone\\:\\ 0\\.023294358223146044\ \(0\)\
\-\ a\\.\\:\\ 0\\.02302964775591995\ \(0\)\
\-\ tsh\\:\\ 0\\.0223131305484176\ \(0\)\
\-\ data\\:\\ 0\\.0222397292400965\ \(0\)\
\-\ particular\\:\\ 0\\.02202601884312134\ \(0\)\
\-\ except\\:\\ 0\\.02080231756843442\ \(0\)\
\-\ \\)\\:\\ 0\\.020582818041729956\ \(0\)\
\-\ hr\\:\\ 0\\.020007490739466227\ \(0\)\
\-\ almost\\:\\ 0\\.019872053830972493\ \(0\)\
\-\ systemic\\:\\ 0\\.01965447406372191\ \(0\)\
\-\ period\\:\\ 0\\.01920786951135318\ \(0\)\
\-\ \\%\\:\\ 0\\.019166548397557766\ \(0\)\
\-\ having\\:\\ 0\\.01887100622954204\ \(0\)\
\-\ cbc\\:\\ 0\\.01835724110674223\ \(0\)\
\-\ \\'s\\:\\ 0\\.018115832868913894\ \(0\)\
\-\ clinically\\:\\ 0\\.01801256837378013\ \(0\)\
\-\ suspected\\:\\ 0\\.01769096147555883\ \(0\)\
\-\ gland\\:\\ 0\\.017496964862464756\ \(0\)\
\-\ absence\\:\\ 0\\.017080904976257756\ \(0\)\
\-\ free\\:\\ 0\\.016909620468357988\ \(0\)\
\-\ occurs\\:\\ 0\\.01686178233925622\ \(0\)\
\-\ uptake\\:\\ 0\\.016322035695645252\ \(0\)\
\-\ 4\\.\\:\\ 0\\.01617538447308076\ \(0\)\
\-\ similar\\:\\ 0\\.016113877975677347\ \(0\)\
\-\ 24\\:\\ 0\\.01597335086839399\ \(0\)\
\-\ \\<\\:\\ 0\\.015856084266835532\ \(0\)\
\-\ referred\\:\\ 0\\.015502555016613661\ \(0\)\
\-\ activity\\:\\ 0\\.015413685715295859\ \(0\)\
\-\ laboratory\\:\\ 0\\.01513986411468301\ \(0\)\
\-\ diagnosed\\:\\ 0\\.015106707484591373\ \(0\)\
\-\ then\\:\\ 0\\.014620033069336971\ \(0\)\
\-\ was\\:\\ 0\\.014254002724235867\ \(0\)\
\-\ inflammatory\\:\\ 0\\.014246711270153962\ \(0\)\
\-\ benign\\:\\ 0\\.0141781267645827\ \(0\)\
\-\ 3\\.\\:\\ 0\\.014057087558368882\ \(0\)\
\-\ \\>\\:\\ 0\\.013649843820521946\ \(0\)\
\-\ disease\\:\\ 0\\.013430168665535617\ \(0\)\
\-\ often\\:\\ 0\\.013108045906344483\ \(0\)\
\-\ 2\\.\\:\\ 0\\.013064635297116626\ \(0\)\
\-\ differential\\:\\ 0\\.013043076102658317\ \(0\)\
\-\ known\\:\\ 0\\.01300024559838375\ \(0\)\
\-\ 1\\.\\:\\ 0\\.01283264022258462\ \(0\)\
\-\ tenderness\\:\\ 0\\.012494770783084776\ \(0\)\
\-\ as\\:\\ 0\\.012428629864366615\ \(0\)\
\-\ decreased\\:\\ 0\\.012215175013098845\ \(0\)\
\-\ demonstrated\\:\\ 0\\.012054903761812345\ \(0\)\
\-\ s\\:\\ 0\\.011782536861127823\ \(0\)\
\-\ she\\:\\ 0\\.011532625680068137\ \(0\)\
\-\ one\\:\\ 0\\.01113332395822425\ \(0\)\
\-\ \\:\\:\\ 0\\.010868027076833318\ \(0\)\
\-\ is\\:\\ 0\\.010813284199706263\ \(0\)\
\-\ symptoms\\:\\ 0\\.010238737869702592\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.010096803065537582\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009902641836453091\ \(0\)\
\-\ or\\:\\ 0\\.009630026432343342\ \(0\)\
\-\ woman\\:\\ 0\\.009489918016773588\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009433746782598174\ \(0\)\
\-\ it\\:\\ 0\\.00923484800256258\ \(0\)\
\-\ also\\:\\ 0\\.008099132661875728\ \(0\)\
\-\ normal\\:\\ 0\\.006440444493264909\ \(0\)\
\-\ there\\:\\ 0\\.006114017098389369\ \(0\)\
\-\ in\\:\\ 0\\.006077844665484447\ \(0\)\
\-\ pain\\:\\ 0\\.005017346959282379\ \(0\)\
\-\ no\\:\\ 0\\.00413675072453751\ \(0\)\
\-\ to\\:\\ 0\\.0041064241196440985\ \(0\)\
\-\ \\,\\:\\ 0\\.00390447209880703\ \(0\)\
\-\ a\\:\\ 0\\.0038134596328711664\ \(0\)\
\-\ for\\:\\ 0\\.0035053276377053615\ \(0\)\
\-\ the\\:\\ 0\\.003323300113067928\ \(0\)\
\-\ of\\:\\ 0\\.0028005721345670297\ \(0\)\
\-\ and\\:\\ 0\\.0025962837365223817\ \(0\)\
\-\ \\.\\:\\ 0\\.0015360376195967139\ \(0\)\
\-\ with\\:\\ 0\\.0005625200773552391\ \(0\)\
